Males | Females | Total | |||||||
Obs | SIR | 95% CI | Obs | SIR | 95% CI | Obs | SIR | 95% CI | |
Total | 492 | 1.51 | 1.38–1.65 | 221 | 1.78 | 1.55–2.03 | 713 | 1.58 | 1.47–1.70 |
Duration of follow-up | |||||||||
1–4 yrs | 274 | 1.99 | 1.76–2.24 | 110 | 2.32 | 1.91–2.80 | 384 | 2.07 | 1.87–2.29 |
5–9 yrs | 130 | 1.31 | 1.10–1.56 | 61 | 1.62 | 1.24–2.08 | 191 | 1.40 | 1.20–1.61 |
≥10 yrs | 88 | 0.99 | 0.79–1.22 | 50 | 1.27 | 0.94–1.68 | 138 | 1.08 | 0.90–1.27 |
Test for linear trend# | <0.01 | <0.01 | <0.01 | ||||||
Calendar year at entry | |||||||||
1965–1974 | 117 | 1.15 | 0.95–1.38 | 41 | 1.29 | 0.93–1.75 | 158 | 1.18 | 1.01–1.38 |
1975–1984 | 226 | 1.59 | 1.39–1.81 | 83 | 1.54 | 1.23–1.91 | 309 | 1.57 | 1.40–1.76 |
1985–1994 | 149 | 1.81 | 1.53–2.13 | 97 | 2.50 | 2.03–3.05 | 246 | 2.03 | 1.79–2.30 |
Test for linear trend# | <0.01 | <0.01 | <0.01 | ||||||
Age at entry | |||||||||
20–44 | 13 | 0.87 | 0.46–1.49 | 16 | 1.27 | 0.72–2.06 | 29 | 1.05 | 0.71–1.51 |
45–59 | 122 | 1.19 | 0.99–1.43 | 67 | 1.53 | 1.19–1.94 | 189 | 1.30 | 1.12–1.49 |
≥60 | 357 | 1.71 | 1.54–1.90 | 138 | 2.03 | 1.70–2.39 | 495 | 1.79 | 1.63–1.95 |
Test for linear trend# | <0.01 | 0.02 | <0.01 | ||||||
Other diagnoses at index hospitalization | |||||||||
Asthma as only diagnosis | 189 | 1.24 | 1.07–1.43 | 89 | 1.43 | 1.15–1.76 | 278 | 1.29 | 1.14–1.45 |
Asthma as main diagnosis | 128 | 1.62 | 1.35–1.93 | 53 | 1.76 | 1.32–2.30 | 181 | 1.66 | 1.43–1.92 |
Asthma as secondary diagnosis | 175 | 1.86 | 1.59–2.15 | 79 | 2.47 | 1.95–3.08 | 254 | 2.01 | 1.77–2.27 |
Dept of index hospitalization | |||||||||
Internal/respiratory medicine | 392 | 1.41 | 1.27–1.56 | 177 | 1.67 | 1.43–1.93 | 569 | 1.48 | 1.36–1.61 |
Other | 100 | 2.09 | 1.70–2.55 | 44 | 2.42 | 1.76–3.25 | 144 | 2.18 | 1.84–2.57 |
Number of hospitalizations during first year of follow-up | |||||||||
1 | 348 | 1.66 | 1.49–1.85 | 149 | 1.81 | 1.53–2.12 | 497 | 1.70 | 1.56–1.86 |
2–3 | 110 | 1.30 | 1.06–1.56 | 55 | 1.70 | 1.28–2.21 | 166 | 1.41 | 1.21–1.65 |
≥4 | 33 | 1.04 | 0.72–1.46 | 17 | 1.77 | 1.03–2.83 | 50 | 1.21 | 0.90–1.59 |
Test for linear trend# | <0.01 | 0.78 | <0.01 | ||||||
Presence of emphysema | |||||||||
No | 486 | 1.51 | 1.38–1.65 | 219 | 1.78 | 1.55–2.03 | 705 | 1.59 | 1.47–1.71 |
Yes | 6 | 1.22 | 0.45–2.66 | 2 | 1.65 | 0.20–5.95 | 8 | 1.31 | 0.56–2.58 |
Presence of chronic bronchitis | |||||||||
No | 301 | 1.20 | 1.07–1.34 | 150 | 1.42 | 1.20–1.67 | 451 | 1.27 | 1.15–1.39 |
Yes | 191 | 2.54 | 2.19–2.93 | 71 | 3.76 | 2.93–4.74 | 262 | 2.79 | 2.46–3.15 |
Histological type of lung cancer | |||||||||
Squamous cell carcinoma | 233 | 1.83 | 1.61–2.09 | 81 | 3.22 | 2.56–4.00 | 314 | 2.06 | 1.84–2.30 |
Adenocarcinoma | 66 | 1.11 | 0.86–1.41 | 43 | 0.99 | 0.71–1.33 | 109 | 1.06 | 0.87–1.27 |
Small cell carcinoma* | 17 | 1.90 | 1.11–3.05 | 15 | 3.18 | 1.78–5.25 | 32 | 2.34 | 1.60–3.31 |
Obs: observed
#: p-value
*: follow-up 1987–1994